We reviewed the paper by Dias et al. 1 with interest in our weekly journal club. As a group we are committed to improving the outcome of EVAR, and were interested to review this study which considered the importance of maintaining reasonable cost without compromising patient safety. Currently a number of leading vascular centres are moving away from regular CT follow up and relying on ultrasound and radiography instead. The paper raised a number of questions which we would like to clarify. Firstly, Dias et al. mentioned that regular CT scans can identify non-vascular pathology of clinical significance; did the authors identify any in their cohort? What were the outcomes of these?
